PT-141 (Bremelanotide) Prescribed Online to Ohio Residents
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
What Is PT-141 (Bremelanotide)?
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Benefits of PT-141 (Bremelanotide)
Works through the brain to enhance desire and arousal
Effective for both men and women
Addresses root causes of low libido rather than just physical response
FDA-approved active ingredient (Vyleesi for women)
Unique central mechanism distinct from PDE5 inhibitors
Ohio is the heart of it all—manufacturing and medicine, agriculture and innovation, world-class cities and charming small towns. OmniRx Health serves every Buckeye. From the corporate corridors of Columbus to the medical excellence of Cleveland, the cultural richness of Cincinnati to the college towns and farming communities throughout, our telehealth platform fits your Ohio lifestyle. Get expert care without fighting I-71 traffic or waiting weeks for an appointment.
Getting PT-141 (Bremelanotide) Prescribed in Ohio
Licensed in OH
Our providers are licensed by the State Medical Board of Ohio for comprehensive telehealth services statewide.
Pharmacy Delivery
Ohio's extensive pharmacy network in Columbus, Cleveland, Cincinnati, and throughout the state ensures rapid prescription access.
Ohio has telehealth laws that support virtual care delivery while ensuring patient safety and provider accountability.
Frequently Asked Questions About PT-141 (Bremelanotide)
Common questions from Ohio residents about PT-141 (Bremelanotide) treatment
Explore Related Sexual Wellness Options
Find the right treatment, in the right state, for you.